Company Filing History:
Years Active: 2014-2024
Title: Innovations of Julie Marie Hicks
Introduction
Julie Marie Hicks is a prominent inventor based in Erie, Colorado. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that target specific receptor tyrosine kinases. With a total of five patents to her name, her work is instrumental in advancing treatments for hyperproliferative diseases.
Latest Patents
One of her latest patents includes the invention of N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases. This invention provides compounds of Formula I wherein B, G, A, E, R, R, R, m, and n are defined, which are useful as type I receptor tyrosine kinase inhibitors. The methods of use of these compounds are aimed at treating hyperproliferative disorders in mammals.
Career Highlights
Julie Marie Hicks is currently associated with Array Biopharma Inc., where she continues to innovate and develop new therapeutic solutions. Her expertise in the field has led to advancements that could potentially improve patient outcomes in various medical conditions.
Collaborations
Some of her notable coworkers include Joseph P. Lyssikatos and Fredrik Pehr Marmsater, who collaborate with her on various projects within the company.
Conclusion
Julie Marie Hicks is a trailblazer in the field of biopharmaceuticals, with her innovative patents paving the way for new treatments. Her contributions are vital in the ongoing fight against hyperproliferative diseases, showcasing the importance of her work in the medical community.